Balloon-Expandable Transcatheter Aortic Valve Replacement: A Comprehensive Review of Current Evidence and Clinical Outcomes
Recommended Citation
Jabri A, Madanat L, Villablanca PA. Balloon-Expandable Transcatheter Aortic Valve Replacement: A Comprehensive Review of Current Evidence and Clinical Outcomes. Interv Cardiol Clin. 2026;15(4):527-534.
Document Type
Article
Publication Date
10-1-2026
Publication Title
Interv Cardiol Clin
Keywords
Humans, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Heart Valve Prosthesis, Prosthesis Design, Treatment Outcome, Aortic Valve, Balloon Valvuloplasty
Abstract
This article outlines the transformative impact of transcatheter aortic valve replacement (TAVR) since its first successful human use in 2002, redefining the management of severe aortic stenosis. Traditionally treated with surgical aortic valve replacement, many elderly patients with comorbidities were unsuitable for surgery. TAVR has emerged as a less invasive and widely adopted alternative, expanding from high-risk to low-risk populations with strong clinical outcomes. Its rapid global uptake and potential role in earlier intervention highlight its clinical significance. The article also introduces the 2 main valve platforms, balloon-expandable and self-expanding, focusing on their design and evolving applications.
Medical Subject Headings
Humans; Transcatheter Aortic Valve Replacement; Aortic Valve Stenosis; Heart Valve Prosthesis; Prosthesis Design; Treatment Outcome; Aortic Valve; Balloon Valvuloplasty
PubMed ID
42648857
Volume
15
Issue
4
First Page
527
Last Page
534
